Detalles de la búsqueda
1.
Anti-CD20-interleukin-21 fusokine targets malignant B cells via direct apoptosis and NK-cell-dependent cytotoxicity.
Blood
; 129(16): 2246-2256, 2017 04 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-28137826
2.
Mammary-tumor-educated B cells acquire LAP/TGF-ß and PD-L1 expression and suppress anti-tumor immune responses.
Int Immunol
; 28(9): 423-33, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-26895637
3.
Antibody-Drug Conjugate αEGFR-E-P125A Reduces Triple-negative Breast Cancer Vasculogenic Mimicry, Motility, and Metastasis through Inhibition of EGFR, Integrin, and FAK/STAT3 Signaling.
Cancer Res Commun
; 4(3): 738-756, 2024 Mar 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38315147
4.
B lymphocyte inhibition of anti-tumor response depends on expansion of Treg but is independent of B-cell IL-10 secretion.
Cancer Immunol Immunother
; 62(1): 87-99, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22772949
5.
Inhibition of Vasculogenic Mimicry and Angiogenesis by an Anti-EGFR IgG1-Human Endostatin-P125A Fusion Protein Reduces Triple Negative Breast Cancer Metastases.
Cells
; 10(11)2021 10 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-34831127
6.
Enhanced inhibition of murine tumor and human breast tumor xenografts using targeted delivery of an antibody-endostatin fusion protein.
Mol Cancer Ther
; 4(6): 956-67, 2005 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-15956253
7.
Targeted delivery of an antibody-mutant human endostatin fusion protein results in enhanced antitumor efficacy.
Mol Cancer Ther
; 10(4): 603-14, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21393427
8.
Model for in vivo progression of tumors based on co-evolving cell population and vasculature.
Sci Rep
; 1: 31, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-22355550
9.
Delivery of NKG2D ligand using an anti-HER2 antibody-NKG2D ligand fusion protein results in an enhanced innate and adaptive antitumor response.
Cancer Res
; 70(24): 10121-30, 2010 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21159634
10.
Potential role of chemokines in immune therapy of cancer.
Isr Med Assoc J
; 4(11): 1054-9, 2002 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-12489506
11.
Augmentation of anti-tumor responses of adoptively transferred CD8+T cells in the lymphopenic setting by HSV amplicon transduction.
Cancer Immunol Immunother
; 57(5): 663-75, 2008 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-17952436
12.
Increased rejection of primary tumors in mice lacking B cells: inhibition of anti-tumor CTL and TH1 cytokine responses by B cells.
Int J Cancer
; 117(4): 574-86, 2005 Nov 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-15912532
13.
Genetically engineered antibodies and their application to brain delivery.
Adv Drug Deliv Rev
; 15(1-3): 147-175, 1995 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35524387
14.
Comparison of the antitumor efficacies of Her-2/neu DNA vaccines inducing contrasting IgG immunity but comparable CTL activity in mice.
Vaccine
; 21(5-6): 521-31, 2003 Jan 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-12531652
15.
An anti-transferrin receptor-avidin fusion protein exhibits both strong proapoptotic activity and the ability to deliver various molecules into cancer cells.
Proc Natl Acad Sci U S A
; 99(16): 10706-11, 2002 Aug 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-12149472
16.
Both the epitope specificity and isotype are important in the antitumor effect of monoclonal antibodies against Her-2/neu antigen.
Int J Cancer
; 102(4): 428-34, 2002 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-12402315
Resultados
1 -
16
de 16
1
Próxima >
>>